No abstract available
Keywords:
Mammalian target of rapamycin inhibitor; Prognosis; Renal cell carcinoma; Sequential therapy; Tyrosine kinase inhibitor.
MeSH terms
-
Adult
-
Age of Onset
-
Antineoplastic Agents / therapeutic use
-
Axitinib
-
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / genetics
-
Carcinoma, Renal Cell / drug therapy*
-
Carcinoma, Renal Cell / genetics
-
Catheter Ablation
-
Child
-
Combined Modality Therapy / methods
-
Everolimus / therapeutic use
-
Fatal Outcome
-
Humans
-
Imidazoles / therapeutic use
-
Indazoles / therapeutic use
-
Indoles / therapeutic use
-
Kidney Neoplasms / drug therapy*
-
Kidney Neoplasms / genetics
-
Male
-
Molecular Targeted Therapy / methods*
-
Niacinamide / analogs & derivatives
-
Niacinamide / therapeutic use
-
Oncogene Fusion
-
Phenylurea Compounds / therapeutic use
-
Pyrroles / therapeutic use
-
Sorafenib
-
Sunitinib
-
Translocation, Genetic
-
Young Adult
Substances
-
Antineoplastic Agents
-
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
-
Imidazoles
-
Indazoles
-
Indoles
-
Phenylurea Compounds
-
Pyrroles
-
TFE3 protein, human
-
Niacinamide
-
Everolimus
-
Sorafenib
-
Axitinib
-
Sunitinib